Submitted by Anonymous (not verified) on 11 May 2026 - 15:00
Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised